StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
5330.KL$1.93+1.05%
Fair $1.93+0.0%

5330.KL

5330.KL

Basic Materials / ChemicalsKuala Lumpur

$1.93

+0.02 (+1.05%)

Fairly Valued+0.0%Fair Value $1.93Fund rank 30/100 · Data gapFallback financials|
SA 56/C
F-Score: 5/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 23%

FCF escenarios

weak_data · normalized FCF $88.1M · quality 60.0/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 40/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

56/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 3 consecutive years
Thesis & Journal · 5330.KLLocal privado en este navegador · 5330.KL
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.9B

P/E

17.5x

↑

EV/EBITDA

10.6x

↓

ROE

12.8%

↑

Gross Margin

21.0%

↑

Debt/Equity

0.37

↑
52-Week Range$2
$1$2

TradingView lightweight chart

5330.KL price, volumen y niveles de valoración

Último $1.930Periodo +0.5%
Fair value: $1.930

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-10.8%

FCF CAGR

+8.6%

FCF margin

8.4%

FCF / Net income

0.91x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.05B · net income $97.2M · FCF $88.1M

2022-FY → 2025-FY

Gross margin

21.0%+3.4% pts

Operating margin

11.3%-1.2% pts

Net margin

9.2%-0.9% pts

FCF margin

8.4%+3.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.05B$1.05B$1.30B$1.31B$1.48B
Net Income$97.2M$97.2M$111.4M$91.8M$150.3M
EBITDA$171.2M$171.2M$194.2M$154.8M$213.8M
EPS——0.500.090.15
Gross Margin21.0%21.0%18.6%16.1%17.6%
Operating Margin11.3%11.3%11.8%9.4%12.4%
Net Margin9.2%9.2%8.5%7.0%10.1%
Balance Sheet
Debt/Equity0.370.370.580.490.45
Current Ratio2.012.01———
Cash Flow
Free Cash Flow$88.1M$88.1M$120.3M$-2.4M$68.9M
Returns
ROE12.8%12.8%15.2%17.6%31.2%
Valuation
P/E17.5517.553.80——
EV/EBITDA10.5810.581.78——
P/B2.532.530.58——
Growth & Yield
Revenue Growth-19.2%-19.2%-0.2%-12.0%—
EPS Growth——445.1%-38.9%—
Dividend Yield2.9%2.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +70.7%

Total return

+70.7%

Start / end P/E

n/dx → n/dx

EPS bridge

0.50 → n/d

Residual

+67.8%

EPS growthn/d
Multiple reratingn/d
Dividend+2.9%
Residual / FX / buybacks / cross-term+67.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.